October 29, 2019

Full content is available for members only

Aimia announces three series of preferred share dividends for quarter.

Active Biotech NeoTX announce dosing of the first patient in Phase 1b trial of naptumomab estafenatox in combination with durvalumab in solid tumours.

Icelandair Group revises upward EBIT guidance for 2019.

Raytheon names new presidents following merger with United Technologies.

Teamsters ratify 10-year contract with Air Canada.

Bremer Bank could be put up for sale.

Central bank says Lebanon could be days away from an economic collapse.

Uber credit cards to see major restructuring.

Top Chinese politician says Libra will not succeed.